# LifeShare Blood Center – FDA Inspection, May 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/bef4675f-8b81-46c4-9c56-69958dd7eac4
Source feed: FDA_Inspections

> FDA inspection 1011812 of LifeShare Blood Center, May 25, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1011812
- Company Name: LifeShare Blood Center
- Inspection Date: 2017-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1181230 - 2022-09-14
- FDA Inspection 1095940 - 2018-12-13
- FDA Inspection 916535 - 2015-02-27
- FDA Inspection 838706 - 2013-05-06
- FDA Inspection 679798 - 2010-08-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/fb1b6b47-f789-40d5-b38b-133b5c9faab1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d